Free Trial

Aviva PLC Sells 212,375 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Cooper Companies logo with Medical background
Remove Ads

Aviva PLC decreased its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 64.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 119,701 shares of the medical device company's stock after selling 212,375 shares during the quarter. Aviva PLC owned approximately 0.06% of Cooper Companies worth $11,004,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Byrne Asset Management LLC bought a new position in Cooper Companies in the 4th quarter worth $33,000. OFI Invest Asset Management purchased a new stake in shares of Cooper Companies during the fourth quarter worth about $34,000. New Age Alpha Advisors LLC bought a new stake in Cooper Companies during the 4th quarter valued at approximately $38,000. West Financial Advisors LLC purchased a new position in Cooper Companies in the 4th quarter worth approximately $49,000. Finally, Atala Financial Inc bought a new position in shares of Cooper Companies during the fourth quarter worth $51,000. Institutional investors own 24.39% of the company's stock.

Analyst Ratings Changes

Several brokerages have commented on COO. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Stifel Nicolaus decreased their price objective on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Piper Sandler reissued an "overweight" rating and issued a $115.00 target price (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Citigroup reduced their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $110.25.

Remove Ads

Get Our Latest Stock Analysis on COO

Cooper Companies Trading Up 1.0 %

Shares of NASDAQ COO traded up $0.75 during mid-day trading on Monday, reaching $78.21. The company had a trading volume of 255,988 shares, compared to its average volume of 1,391,631. The Cooper Companies, Inc. has a 52 week low of $69.81 and a 52 week high of $112.38. The business's 50-day moving average is $84.64 and its 200-day moving average is $94.52. The stock has a market cap of $15.64 billion, a price-to-earnings ratio of 40.11, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Read More

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Massive Buybacks: 3 Stocks Insiders Are Buying Up

Massive Buybacks: 3 Stocks Insiders Are Buying Up

Insiders are making big bets on these stocks—should you? Stock buybacks can signal confidence and future growth, and 3 companies are making aggressive moves.

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads